Table 4 Annual resource utilization and direct costs
From: Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia
Type | Group 3 PH | Controls | Unadjusted DID (95% CI) | Adjusted DID (95% CI) | P value | ||||
|---|---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | Difference | Baseline | Follow-up | Difference | ||||
All-cause utilization, n | |||||||||
Inpatient admissions | 3.7 (8.0) | 6.2 (11.4) | 2.5 (10.6) | 2.5 (6.1) | 2.2 (5.9) | −0.2 (6.0) | 2.7 (2.2–3.2) | 3.1 (2.6–3.7) | <.0001 |
Outpatient visits | 17.6 (22.3) | 24.6 (27.8) | 7.0 (21.7) | 9.2 (12.6) | 9.6 (15.4) | 0.4 (11.7) | 6.6 (5.6–7.6) | 6.5 (5.5–7.6) | <.0001 |
Physician office visits | 18.6 (14.2) | 20.3 (15.0) | 1.7 (12.1) | 14.3 (12.6) | 13.6 (12.7) | −0.8 (10.0) | 2.5 (1.8–3.1) | 2.8 (2.1–3.5) | <.0001 |
ED visits | 0.8 (2.1) | 0.9 (2.3) | 0.2 (1.8) | 0.4 (0.9) | 0.5 (1.1) | 0.1 (1.2) | 0.1 (0.02–0.20) | 0.1 (0.05–0.2) | 0.002 |
Prescription claims | 78.3 (50.3) | 86.1 (50.7) | 7.8 (31.0) | 58.8 (43.7) | 61.0 (45.1) | 2.2 (21.2) | 5.6 (3.9–6.9) | 6.1 (4.5–7.7) | <.0001 |
All-cause costs, US$ | |||||||||
Total | 34,040 (71,571) | 44,732 (104,621) | 10,691 (89,617) | 8102 (14,108) | 7051 (12,887) | −1051 (15,432) | 11,743 (7972–15,513) | 10,240 (6266–14,214) | <.0001 |
Inpatient | 11,485 (51,815) | 15,852 (84,677) | 4367 (81,147) | 1764 (8963) | 1015 (4668) | −749 (9548) | 5116 (1728–8503) | 4280 (706–7855) | .019 |
Outpatient | 8429 (28,357) | 11,875 (34,344) | 3446 (23,809) | 2171 (5804) | 1908 (8281) | −263 (8736) | 3709 (2657–4760) | 3309 (2198–4421) | <.0001 |
Physician office | 1655 (3599) | 1825 (4948) | 170 (4105) | 853 (2285) | 816 (3001) | −37 (2290) | 207 (12–402) | 238 (31–444) | .024 |
ED | 372 (1916) | 385 (1894) | 13 (1497) | 79 (389) | 113 (1471) | 35 (1495) | −22 (−110–66) | −36 (−130–56) | .44 |
Prescription | 12,099 (27,938) | 14,795 (29,228) | 2696 (18,807) | 3235 (4622) | 3198 (4,371) | −37 (2412) | 2733 (1947–3519) | 2449 (1616–3282) | <.0001 |